Ruling Puts Drug Cos. In Prime Position To Avert State Court

Law360, New York (November 14, 2012, 9:53 PM EST) -- A New York federal judge ruled Friday that state-law claims targeting three generic-drug manufacturers involve federal questions consequential enough to prevent their removal to state court, a decision that should help other generics makers keep cases in the friendlier confines of federal court.

U.S. District Judge William Kuntz denied a remand motion filed by a group of plaintiffs claiming they suffered tissue damage from taking generic anti-seizure drugs manufactured by Sun Pharmaceutical Industries Inc., Taro Pharmaceuticals USA Inc. and Caraco Pharmaceutical Laboratories Ltd. The judge also...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Bowdrie et al v. Sun Pharmaceutical Industries, Ltd. et al


Case Number

1:12-cv-00853

Court

New York Eastern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

William F. Kuntz, II

Date Filed

February 21, 2012

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.